Yakira Capital Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Yakira Capital Management's XENT Position: Q2 2022 in Review
Yakira Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 174,099 shares — an estimated $4.88M sold.
Yakira Capital Management first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $4.88M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Yakira Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Yakira Capital Management sold 174,099 Intersect ENT, Inc shares in Q2 2022, an estimated $4.88M.
- Yakira Capital Management first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
- Yakira Capital Management's Intersect ENT, Inc position peaked at $4.88M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Yakira Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.